Gene Therapy
Turning white blood cells into ‘living cancer drugs’ with electric shocks
A promising new class of cancer treatments recruits the cells in our blood to fight tumors, using powerful gene-editing tools ...
Making CAR-T cancer treatments less risky with ‘safety switches’ and precision targeting
A majority of patients who receive CAR-T cell therapy react [with] varying degrees of severity. Those same T cells that ...
Muscular dystrophy targeted with promising gene therapy
An experimental gene therapy appeared to dramatically increase the production of a muscle-making protein in three young boys with Duchenne ...
Key question facing new gene therapy for blood disorders: How long will it last?
New versions of Bluebird Bio’s gene therapy for inherited blood disorders yielded significant benefits for patients, according to updated results from ...
Is gene therapy the answer to spinal cord injuries?
Here’s the thing about the spinal cord: you’ve only got one. And right now, if you injure it, doctors can’t ...
Expanded genetic testing of newborns could help us get the most out of new gene therapies
The company behind [spinal muscular atrophy drug] AveXis, is seeing the most dramatic results in children who are treated in ...
Who should pay for million-dollar life-saving gene therapies?
While life-changing and life-saving gene therapies are going on the market, they have price tags that many cannot pay for ...
Quick fix: Gene therapy could offer less invasive pet contraception
Might gene therapy provide a one-time, far less invasive way to ensure that cats and dogs do not beget kittens ...
Using patient registries to track effectiveness of cell and gene therapy trials
Due to advances in rare-disease research and individualized cell and gene therapies, there has been a recent crop of treatments ...
First Luxterna results: Does the $850,000 gene therapy work?
About eight weeks earlier, [Jack Hogan had] been the first person to get an $850,000 therapy called Luxturna since it had hit the market ...
Can we reverse aging in dogs through gene therapy? If so, humans could be next.
The world’s most influential synthetic biologist is behind a new company that plans to rejuvenate dogs using gene therapy. If ...
Paying for pricey gene therapy without insurance: Amish community faces challenge
[A]t $850,000 a person, Luxturna was more budget-busting than just about any other drug. [Company] Spark had proposed a few different ways of helping ...
Death of controversial biohacker Aaron Traywick puts movement at ‘crossroads’
At just 28, [Aaron] Traywick was among the most infamous figures in the world of biohacking—the grandiose CEO of a ...
Gene therapy research gets boost from parent-led crowdfunding
It’s a compelling narrative: A parent learns that his or her child has a fatal disease with no cure, and, ...
Beta thalassemia patients could be freed from life of blood transfusions by one-time gene therapy
A one-time, experimental treatment for an inherited blood disorder has shown dramatic results in a small study. It’s a major ...
Pediatric brainstem cancer eradicated in mice using CAR-T treatment
Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University ...
Gene therapy and rare diseases: ‘Is curing patients a sustainable business model?’
An analyst at Goldman Sachs asked a troubling question...about gene therapy. “Is curing patients a sustainable business model?” In social media, reactions ...
Travel to Mars: Can gene therapy help us clear deadly radiation hurdle?
An international group of researchers has come up with a new plan to help astronauts survive high-level radiation in space ...
Pursuing ‘organic gene therapy’ for sickle cell anemia and beta thalassemia
Scientists in Australia have solved a 50-year-old mystery that could lead to the development of new gene therapies for blood ...
Money magnets: Wall Street enamored by promise of human gene editing, gene therapies
Venture capitalists and investors are pouring money into the genomics sector, seeking to capitalize on breakthroughs in CRISPR gene editing ...
House ‘right to try’ law passes, sent to Senate: What it could mean for fragile patients
The US House of Representatives passed a federal "right-to-try" bill [March 21], leaving many Americans wondering what the move could ...
Highly anticipated Luxturna gene therapy for blindness costs $850,000
The trouble had started over a decade ago, when the Hogans noticed something wasn’t right with their son Jack...When they ...
FDA puts clinical hold on Solid Biosciences’ gene therapy trial for Duchenne muscular dystrophy over toxicity concerns
The FDA has imposed a full clinical hold on Solid Biosciences’ Phase I/II trial for its lead candidate, the Duchenne ...
Safer and cheaper: New research in ‘nanospears’ could transform gene therapies
UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called “nanospears” for the targeted delivery of biomolecules ...
Viewpoint: GlaxoSmithKline abandonment of rare disease gene-therapy drug program because it’s not a money generator hurts children
When GlaxoSmithKline, long a global leader in the effort to pioneer gene replacement therapies, announced it would halt its drug ...
Cryogenics logistics: Delivering CAR-T treatments at minus 240 degrees to save lives
Last year, the FDA approved the first CAR T-cell treatments—a new class of promising therapies that train the body’s immune ...
Immunotherapy mystery: Drugs treat ovarian cancer ‘when they should not have’
[Four women with rare ovarian cancer], strangers to one another living in different countries, asked their doctors to try new ...